Individuals using anti-obesity medications often experience reduced appetite and decreased food intake, making nutritional quality crucial. A new review provides clinicians with evidence-based nutritional guidelines, emphasizing the “5A’s Model” for effective patient communication and management. Nutritional recommendations include personalized caloric needs, high protein intake, and balanced macronutrients, with ongoing monitoring to manage potential nutrient deficiencies and support optimal health outcomes.
A new review presents nutritional guidelines for patients using anti-obesity medications, emphasizing the importance of maintaining diet quality and monitoring to prevent deficiencies, and highlights the need for further research on new treatments. Individuals using anti-obesity medications often find that their appetite decreases, leading to a lower food intake. Consequently, the quality of the diet becomes crucial as it must fulfill nutritional needs with less food consumed.
To support this, medical experts have compiled a set of evidence-based dietary guidelines to help clinicians guide patients on anti-obesity medications. These recommendations have been detailed in a review published in Obesity , the flagship journal of The Obesity Society (TOS) . “Our evidence-based review aims to equip clinicians with knowledge and tools to help support optimal nutritional and medical outcomes for their patients treated with anti-obesity medications,” said Eli Lilly and .